MedComm - Oncology
Издатель: Wiley · ISSN 27696448 · 10 статей
-
Targeting Therapy‐Induced Vulnerabilities in Colorectal Cancer
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Reframing Natural Killer Cell Biology for Cancer: From Cytotoxic Potential to Context‐Matched Immune States
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
β‐Arrestin1 Promotes Prostate Cancer Progression via Modulating ESRP1‐Mediated Alternative Splicing of CD44
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
A New Regulator Caspase‐5C Drives Intestinal Homeostasis by Potentiating Wnt Signaling Through Adenomatous Polyposis Coli (APC) Cleavage
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Circular RNA circERBB2 Promotes Tumorigenesis via the miR‐1587/CBX2 Axis and Epigenetic Silencing of PTEN in Bladder Cancer Cells
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Separating Tobacco Exposure From Ancestry in East Asian and Western Lung Adenocarcinoma
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Intratumoral CTLA‐4 Blockade: Decoupling Local Immune Remodeling From Systemic Toxicity
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Cross‐Modal Artificial Intelligence Integrating Dynamic MRI and Clinical Data for Breast Cancer Diagnosis and Nodal Metastasis Prediction
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Issue Information
MedComm – Oncology, Volume 5, Issue 4, December 2026.
-
Association Between BMI and the Efficacy and Safety of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Propensity Score Matched Cohort Study (CAMELIA)
MedComm – Oncology, Volume 5, Issue 4, December 2026.